Contraceptive Risk : : The FDA, Depo-Provera, and the Politics of Experimental Medicine / / William Green.

• Superior document: Title is part of eBook package: De Gruyter New York University Press Complete eBook-Package 2017
• VerfasserIn: Green, William,
• Place / Publishing House: New York, NY : : New York University Press, , [2017]; ©2017
• Year of Publication: 2017
• Language: English
• Series: Biopolitics ; 12
• Physical Description: 1 online resource
• Other title: Frontmatter --; Contents --; Preface and acknowledgments --; Note to the reader --; Introduction. The odyssey of depo- provera --; 1. The Grady hospital study: the corruption of contraceptive research --; 2. The twenty- five-year fda approval controversy: cancer and the politics of acceptable risk --; 3. Contraceptive chaos: unapproved use and Upjohn v. Macmurdo --; 4. Marketing approval and litigation: osteoporosis and the realities of medical risk --; 5. Chemical castration: the johns hopkins clinic and people v. gauntlett --; Conclusion. Contraceptive drug risk failure, human dignity, and a duty to act --; Glossary of legal and medical terms --; Notes --; Index --; About the author
• Format: Mode of access: Internet via World Wide Web.
• ISBN: 9781479825929; 9783110728972
• DOI: 10.18574/nyu/9781479876990.001.0001
• Access: restricted access
• Hierarchical level: Monograph
• Statement of Responsibility: William Green.

The story of Depo-Provera joins the national struggle over the drug's FDA approval to the state legal issues raised by its contraceptive and criminal justice uses.Depo-Provera is known as an injectable hormonal birth control method, but few are familiar with its dark and complicated history. Depo-Provera was tested on women since the mid-1960s without their informed consent until it was FDA-approved in 1992, but never FDA-approved as chemical castration for male sex offenders.Contraceptive Risk is William Green's landmark study of Depo-Provera. Based on a fascinating combination of archival materials and interviews, the book is framed as three interconnected stories told by Judith Weisz, who chaired the FDA's Public Board of Inquiry on Depo-Provera, a scientific court; by Anne MacMurdo who brought a products liability suit against Upjohn, the drug's manufacturer, for the deleterious side effects she suffered from the drug's use; and by Roger Gauntlett, an Upjohn heir who, when he was convicted of sexual assault, refused to take a dose of his family's own medicine as a probation condition. Together these three stories of Depo-Provera's convoluted fifty year odyssey call for a paradigm shift in pharmaceutical drug development.Contraceptive Risk is a thoroughly researched and engrossing approach to the scientific, political and institutional forces involved in health law and policy, as well as the multifaceted politics of measuring risk.